
Opinion|Videos|July 5, 2024
Common Adverse Reactions to EGFR Therapy
Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.
Advertisement
Episodes in this series

- Provide a broad overview of common adverse effects associated with EGFR-targeted therapies in metastatic NSCLC.
- What proactive strategies do you recommend for preventing dermatologic toxicities, such as rash and acneiform eruptions, in patients receiving EGFR-targeted therapies?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
4
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
5






































































































